SAB Biotherapeutics
SABS
SABS
38 hedge funds and large institutions have $3.28M invested in SAB Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
